Moderna Inc. entered the new year on the heels of a worsening stock performance in 2024. The Cambridge drugmaker’s stock dropped even further after lowering its expected revenue range for 2025 ...

Inhaled corticosteroids all share properties that make them effective topical antiinflammatory agents for treatment of asthma with minimal adverse systemic effects, particularly when administered ...

ZJ Daskalakis has also received speaker funding through Sepracor Inc. and AstraZeneca, and has served on the advisory board for Hoffmann-La Roche Ltd. This work was supported by the Ontario Mental ...